Study explorer (study characteristics and results) method abbreviations

display ongoing studies
Study studied treatmentcontrol treatmentpatientsrisk of biassample sizes Results

COVID 19 hospitalized meta-analysis

GRECCO-19, 2020
RCTcolchicinestandard of careCOVID 19 hospitalizedsome concern
55/50 suggested
    no demonstrated benefit a
  • suggested 89 % decrease in clinical worsening with a moderate degree of certainty due to some concern in risk of bias

COVID-19 mild to moderate meta-analysis

Lopes MIF, 2020
RCTcolchicineplaceboCOVID-19 mild to moderatehigh
17/18 no results

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);